Recent Press: Design News
Excerpt:
With Minnetronix Medical’s help, Vail Scientific aims to bring sepsis screening to triage. The companies are developing a portable device to screen for sepsis risk by measuring nitric oxide in patient breath.
Measuring nitric oxide in patient breath might give clinicians a faster tool for screening for sepsis risks.
A range of laboratory tests of blood and urine samples are currently used to help doctors diagnose sepsis, but they may be time consuming. Vail Scientific sees an opportunity to bring sepsis screening to triage, using an alternative to blood and urine tests. Calling nitric oxide a “critical signaling molecule for sepsis risk,” the company is developing its proprietary VSNO technology to measure exhaled nitric oxide to assess such risk quickly and non-invasively. Minnetronix Medical, Vail’s engineering and manufacturing partner, is helping realize that vision.
“With sepsis, speed and accuracy can help save lives,” explains Tom Burke, CEO of Vail Scientific, in a statement. “The Minnetronix team helped make our technology viable in a device designed for use at the triage stage of a patient workflow. They understood the science and brought their integrated electronics, hardware, and software expertise to the challenge of making VSNO into a better way to address the global issue of sepsis.”